People Background Check
Find People:

Joanne L Maki, Age 6720 Bright Mountain Rd, Cullowhee, NC 28723

Get Report
Known as:
Joanne L Stansberry Joanne Maki Stansberry Joanne M Stansberry Jl Maki Jo Anne Lmaki Joann Stansberry Maki Jl
Related to:
Greg D Lopez 49

Joanne Maki Phones & Addresses

3121 Smithonia Rd, Colbert, GA 30628 (706) 788-2841

3221 Smithonia Rd, Colbert, GA 30628 (706) 788-2841

Lexington, GA

Madison, GA

Athens, GA

Emails

m***[email protected]

Mentions for Joanne L Maki

Joanne Maki resumes & CV records

Resumes

Joanne Maki Photo 20

Technical Director, Veterinary Public Health, North America

Location:
3221 Smithonia Rd, Colbert, GA 30628
Industry:
Pharmaceuticals
Work:
Boehringer Ingelheim
Technical Director, Veterinary Public Health, North America Boehringer Ingelheim Animal Health - Us Jan 2014 - Jul 2017
Technical Director, Veterinary Public Health,Global Commercial Development Boehringer Ingelheim Animal Health - Us Jan 2014 - Jul 2017
Veteriary Public Health, Global Commercial Development, Technical Director Merial, A Sanofi Company 2009 - 2014
Veterinary Public Health, Rabies Franchise Director, Global Merial, A Sanofi Company 2005 - 2009
Veterinary Public Health, Rabies Technical Director, Global Merial, A Sanofi Company 2005 - 2009
Global Tecnical Director, Veterinary Public Health Merial, A Sanofi Company 2003 - 2005
Us Wildlife Rabies Business Manager
Education:
The University of Georgia 1989 - 2002
Doctorates, Doctor of Philosophy, Microbiology, Philosophy University of Tennessee, Knoxville 1987 - 1991
Master of Science, Masters, Medicine Louisiana State University 1979 - 1983
Doctorates, Doctor of Veterinary Medicine, Medicine West Virginia University 1975 - 1979
Bachelors, Bachelor of Science, Animal Science
Skills:
Rabies, Vaccines, Infectious Diseases, Immunology, Molecular Biology, Pharmaceutical Industry, Biotechnology, Veterinary Medicine, Microbiology, Epidemiology, Research, Veterinary, Cross Functional Team Leadership, Strategic Planning, Technical Leadership, Mucosal Immunology, Virology, Public Health
Joanne Maki Photo 21

Joanne Maki

Joanne Maki Photo 22

Program Manager At Merial

Position:
Program Manager at Merial
Location:
Athens, Georgia Area
Industry:
Pharmaceuticals
Work:
Merial
Program Manager

Publications & IP owners

Us Patents

Vaccination Of Skunks And/Or Mongooses Against Rabies

US Patent:
2005028, Dec 22, 2005
Filed:
Jun 20, 2005
Appl. No.:
11/156829
Inventors:
Joanne Maki - Colbert GA, US
International Classification:
F23J013/08
C12Q001/68
F23J013/06
A61K031/70
A01N043/04
A61K039/12
US Classification:
435006000, 454005000
Abstract:
The present invention relates to recombinant anti-rabies vaccines and the oral administration of such vaccines to skunks and/or mongooses. Advantageously, the anti-rabies vaccine may comprise a recombinant vaccinia virus containing a rabies glycoprotein gene. The invention encompasses methods of vaccinating skunks and/or mongooses by administration of an anti-rabies vaccines which may comprise a recombinant vaccinia virus containing a rabies glycoprotein gene.

Adjuvanted Rabies Vaccine With Improved Viscosity Profile

US Patent:
2012026, Oct 25, 2012
Filed:
Apr 20, 2012
Appl. No.:
13/451667
Inventors:
Joanne L. Maki - Colbert GA, US
Tricia Lynn Fry - Fort Collins CO, US
Jerome Cornelius Hurley - Fort Collins CO, US
Lowell Allen Miller - Greeley CO, US
International Classification:
A61K 39/205
A61P 31/14
A61K 39/00
US Classification:
4241991
Abstract:
The present invention relates to adjuvanted recombinant anti-rabies vaccines and the oral administration of such vaccines to raccoons and other wildlife. Advantageously, the anti-rabies vaccine may comprise a recombinant vaccinia virus containing a rabies glycoprotein gene. The invention encompasses methods of vaccinating raccoons and other wildlife by administration of an anti-rabies vaccines which may comprise a recombinant vaccinia virus containing a rabies glycoprotein gene, in combination with an adjuvant which increases both vaccine viscosity and efficacy. The invention provides effective oral recombinant vaccines used in oral rabies vaccination (ORV) programs for wildlife, effective at protecting raccoons, gray foxes, coyotes, and other animals.

Alvac Poxvirus-Rabies Compositions And Combination Compositions And Uses

US Patent:
5843456, Dec 1, 1998
Filed:
Jun 7, 1995
Appl. No.:
8/486969
Inventors:
Enzo Paoletti - Delmar NY
Joanne Maki - Colbert GA
Assignee:
Virogenetics Corporation - Troy NY
International Classification:
A61K 39275
A61K 39295
A61K 39205
US Classification:
4241991
Abstract:
Attenuated recombinant viruses containing DNA encoding a rabies virus antigen in a "cocktail" or combination or multivalent compositions well as methods for making and using the compositions, expression products therefrom, and antibodies generated, are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The compositions and products therefrom and antibodies generated have several preventive, therapeutic and diagnostic uses.

Possible Relatives

Debbie D Maki  Denise L Maki  Dave E Maki  Douglas O Maki  Ellen L Maki  Erica Maki  Erik R Maki  Joanne R Stancil  Joanne L Stang  Joanne E White 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.